Young Jun Kim | Pharmaceutical Science | Best Researcher Award

Prof. Dr. Young Jun Kim | Pharmaceutical Science | Best Researcher Award

professor, Korea university, South Korea

πŸ“Œ Prof. Dr. Young Jun Kim is a distinguished food scientist πŸ₯Ό specializing in functional food, biotechnology, and nutrition. He is a Professor at Korea University (2013–present) and serves as Dean of the Dept. of Food and Biotechnology. He earned his Ph.D. in Food Science from Cornell University (2001), focusing on conjugated linoleic acids (CLA) in dairy products. He has held key positions, including Business Director at Caregen Co., Ltd. and Executive Vice Chairman of the Dietary Supplement Review Board. His research spans cholinergic compounds, antioxidants, and bioflocculants. Recognized with multiple awards, he continues to shape food science and regulatory policies. πŸ†

Publication Profile

Scopus

πŸŽ“ Academic Background

Prof. Dr. Young Jun Kim holds a Ph.D. in Food Science πŸ₯Ό from Cornell University (2001), where his research focused on the production of conjugated linoleic acids (CLA) by rumen bacteria 🦠 and their enhancement in dairy products πŸ₯›. He earned his M.S. in Food Science and Technology from Korea University (1996), investigating bioflocculant production by Corynebacterium sp. K-199 πŸ§ͺ. His academic journey began with a B.S. in Food Biotechnology from Korea University (1994), where he developed expertise in biotechnological applications in food science 🍽️. His research has significantly contributed to nutrition and functional food innovations. πŸš€

πŸ”¬ Research Experience

Prof. Dr. Young Jun Kim has an extensive research background in food science, biotechnology, and functional compounds πŸ§ͺ. As a Visiting Professor at the University of Saskatchewan (2023–2024), he explored cholinergic compounds for health, muscle strength improvement πŸ’ͺ, and Ξ±-GPC functionality. His postdoctoral research at Cornell University (2002–2004) involved cellulosome construction and polyphenol recovery from apple peel 🍏. He also worked on Arg-CLA’s antioxidant and anticancer properties at Seoul National University (2002). Earlier, at Boyce Thompson Institute, he contributed to edible vaccine development πŸ₯. His graduate research at Cornell and Korea University focused on CLA-enriched dairy πŸ₯› and bioflocculants for wastewater treatment. 🌿

πŸ† Honors and Awards

Prof. Dr. Young Jun Kim has received numerous prestigious awards for his contributions to food science and nutrition πŸ§ͺ. He was honored with the Minister of Science and ICT Commendation (2023) for fulfilling national R&D missions and received the Best Paper Award at the Korean Society of Food and Nutrition Science Conference (2023) πŸ“œ. His contributions to public health and nutrition earned him recognition from the U.S. Secretary of Health and Human Services (2021) πŸ‡ΊπŸ‡Έ. He has also been listed in Marquis Who’s Who in Medicine and Healthcare (2009–2010) and won multiple research and lecture awards from Cornell University, Korea University, and IFT πŸŽ“.

πŸ”¬ Research Focus

Prof. Dr. Y.J. Kim specializes in food science, nutrition, and bioactive compounds πŸ₯—πŸ§ͺ. His research explores functional foods, fermentation, antioxidants, and muscle atrophy prevention. Recent studies focus on Arriheuk wheat sprout extract for muscle health, Ξ±-Glycerylphosphorylcholine production in fermented foods, and anti-inflammatory effects of barley sprout fermentation 🌱. Additionally, he investigates sleep-enhancing compounds, food sensory optimization, and bioactive extracts from plants 🍏🌿. His expertise extends to flavor chemistry, browning prevention in fresh produce, and interleukin inhibition for health applications πŸ₯. His work significantly contributes to nutritional science and functional food development.

Publication Top Notes

  • Suppressive Effects of Arriheuk Wheat Sprout Extract on Muscle Atrophy in Dexamethasone-Induced C2C12 Myotubes and a Mouse Model
    Year: 2024 🧬
  • Production of Ξ±-Glycerylphosphorylcholine in Fermented Roots, Tubers, and Fruits
    Year: 2024 🍠
  • UP165, Standardized Corn Leaf Extract and its Active Component 6-Methoxybenzoxazolinone Induce Non-Rapid Eye Movement Sleep through Melatonergic and GABAergic Mechanisms
    Year: 2024 🌿
  • Characterization of Taste and Aroma Profile in Pomegranate (Punica Granatum L.) Seed Oil Using Electronic Sensors, GC-MS/Olfactometry
    Year: 2024 🍎
  • Validation of Optimization Methods for Sensory Characteristics Using Rate-All-That-Apply and Intensity Scales: A Case Study of Apple Juice
    Year: 2024 🍏
  • Antioxidant Activity of Extracts of Balloon Flower Root (Platycodon Grandiflorum), Japanese Apricot (Prunus Mume), and Grape (Vitis Vinifera) and Their Effects on Beef Jerky Quality
    Year: 2024 πŸ‡
  • Prediction Model of Browning Inhibitor Concentration and its Optimal Composition for Mass Processing of Ready-to-Eat Fresh-Cut β€˜Fuji’ Apple (Malus Domestica Borkh.) Strains
    Year: 2024 🍏
  • Identification of Interleukin (IL)-33 Inhibitory Constituents from Canavalia Gladiata Pods
    Cited by: 0
    Year: 2024 🌿
  • The Inhalation Effect of Osmanthus Fragrans var. Aurantiacus on Physiological Parameters in Chronically Stressed Rats
    Cited by: 1
    Year: 2024 🌸
  • Anti-Inflammatory Effects of Barley Sprout Fermented by Lactic Acid Bacteria in RAW264.7 Macrophages and Caco-2 Cells
    Cited by: 3
    Year: 2024 🌾

Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Prof. Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Prof. Fatmah Alasmary, Saudi Food and Drug Authority, Saudi Arabia

Professor at King Saud University, specializing in organic chemistry. Dr. Alasmary has extensive experience in academia and leadership, with a PhD from the University of Bradford. Currently, she serves as Director of the Drug Lab at the Saudi Food and Drug Authority. Her research interests include antimicrobial agents and nanomaterials. Dr. Alasmary has mentored numerous students and has held key roles in various scientific committees. She is a member of the Saudi Chemical Association, the Royal Society of Chemistry, and the American Chemical Society. πŸ§‘β€πŸ”¬πŸ‘©β€πŸ«πŸ”¬

Publication Profile

Google Scholar

Work Experience πŸŒπŸ’Ό

Prof. Fatmahalasmary is a distinguished academic and professional, currently serving as the Director of Drug Lab at Saudi Food and Drug Authority, Riyadh. She oversees quality control, safety standards, and international accreditation efforts for medicines and cosmetics. As Chief of Senior Expert International Communication, she leads food standards initiatives for Saudi Arabia, managing ISO committees and Codex committees. Previously, she was Vice Chairman at King Saud University’s Chemistry Department, coordinating research, teaching, and international collaborations. Prof. Fatmahalasmary’s leadership spans teaching, curriculum development, and guiding postgraduate research, exemplifying excellence in both academic and professional spheres. πŸ“šπŸŒπŸ‘©β€πŸ”¬

 

Qualifications πŸŽ“πŸŒŸ

Prof. Fatmahalasmary holds a PhD in Chemistry from the University of Bradford, England (2013), where her thesis focused on the synthesis and evaluation of benzimidazole derivatives as potential antimicrobial agents. She earned a Master of Science in Chemistry from King Saud University, KSA (2008), with a thesis on the synthesis and study of quinoxaline derivatives. Additionally, she completed her Bachelor of Science in Chemistry at King Saud University, KSA (2001), graduating with honors. Her academic journey highlights a strong foundation in chemistry and a commitment to research excellence. πŸ§ͺπŸ“˜πŸ‘©β€πŸ”¬

 

Additional Experience πŸŒπŸ”¬

Prof. Fatmahalasmary has actively participated in over 22 workshops focused on management, planning, and quality development. She is a member of several prestigious associations, including the Saudi Chemical Association, Royal Society of Chemistry, and American Chemical Society. Her roles have included coordinating committees at King Saud University (KSU), such as the Development and Quality Committee and Labs Committee. Prof. Fatmahalasmary has also been involved in thesis defenses, scientific symposia, and national exhibitions. She holds patents for innovative extracts and is certified in ISO 9001:2015 and as a Certified Innovation Professional. πŸ“šπŸ’‘πŸ“ˆ

 

Research Focus

Prof. Fatmah Ali S Alasmary’s research spans various fields, including antimicrobial agents 🦠, biological chemistry 🧬, and medicinal chemistry πŸ’Š. She has contributed significantly to the development of benzimidazole derivatives as potential antimicrobial agents, as well as carbonic anhydrase inhibitors targeting various pathogens. Her work also delves into perovskite materials πŸ—οΈ, photocatalysis βš›οΈ, and nanomaterials πŸ§ͺ with applications in sensing and biomedical fields. Prof. Alasmary has been actively involved in computational studies of drug design πŸ’», enzyme inhibition πŸ§ͺ, and therapeutic applications for diseases like malaria and cancer.

 

Publication Top Notes Β 

  • Tin versus lead redox chemistry modulates charge trapping and self-doping in tin/lead iodide perovskites (186 citations, 2020) πŸ”‹
  • Synthesis and evaluation of selected benzimidazole derivatives as potential antimicrobial agents (140 citations, 2015) πŸ’Š
  • Inhibition of the Ξ²-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates (41 citations, 2017) 🦠
  • Direct Access to α‐Aminosilanes Enabled by Visible‐Light‐Mediated Multicomponent Radical Cross‐Coupling (36 citations, 2021) πŸ’‘
  • Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3 H)-ones as … (35 citations, 2015) πŸ”¬
  • Analysis of Alpina officinarum Hance, chemically and biologically (30 citations, 2019) 🌿
  • Combined computational and experimental investigation on the nature of hydrated iodoplumbate complexes: Insights into the dual role of water in perovskite precursor solutions (28 citations, 2020) πŸ’§
  • The first activation studies of the Ξ·-carbonic anhydrase from the malaria parasite Plasmodium falciparum with amines and amino acids (28 citations, 2018) 🦠
  • New quinoxalinone inhibitors targeting secreted phospholipase A2 and Ξ±-glucosidase (28 citations, 2017) πŸ§ͺ
  • Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach (27 citations, 2021) 🦠

 

Maryam Tabarzad | Pharmaceutical Science | Best Researcher Award

Maryam Tabarzad | Pharmaceutical Science | Best Researcher Award

Assist Prof Dr Maryam Tabarzad, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Iran

Based on Dr. Maryam Tabarzad’s profile, she appears to be a strong candidate for the Best Researcher Award due to several key factors:

Publication profile

google scholar

Educational Background

  • MSc in E-learning in Medical Education (2023): Focused on enhancing lab skills through augmented reality in pharmacy students.
  • PhD in Pharmaceutical Biotechnology (2014): Specialized in DNA aptamers against Coagulation Factor VIII.
  • Pharm.D. (2007): Conducted research on bis(4-nitroaryl-1,4-Dihydropyridine) with pharmacological evaluations.

Professional Experience

  • Assistant Professor: Protein Technology Research Center, Shahid Beheshti University of Medical Science (2014-present).
  • Vice-Chancellor of Research Affairs: Protein Technology Research Center (2018-present).
  • Editorial Roles: Managing Editor for Trends in Peptide and Protein Sciences, Associate Editor for Iranian Journal of Pharmaceutical Research, and Editorial member for Future Natural Products.

Notable Publications

  1. Fathi et al. (2024): Investigated antimicrobial peptides for wound healing, published in Burns (Q2, IF: 3.2).
  2. Fathi et al. (2024): Explored structural features of antimicrobial peptides in Bioorganic Chemistry (Q1, IF: 5.1).
  3. Yazdanicherati et al. (2024): Studied the effect of antimicrobial peptides on gold nanoparticles, published in Modares Journal of Biotechnology.

Teaching Experience

  • Extensive teaching roles in pharmaceutical and medical biotechnology across various institutions, including University of Science and Culture, Gilan University of Medical Sciences, and Shahid Beheshti University of Medical Sciences.

Thesis Supervision

  • Supervised multiple Ph.D. and MSc theses in areas such as biosensors, peptide-nanomolecule interactions, and cancer research.

Conclusion

Dr. Maryam Tabarzad’s impressive academic credentials, significant contributions to pharmaceutical biotechnology, influential editorial roles, and robust teaching and supervisory experience make her a highly suitable candidate for the Best Researcher Award. Her research, particularly in the design and development of antimicrobial peptides and aptamers, along with her leadership in research and education, underscores her excellence in the field.

Publication top notes

Therapeutic applications of nucleic acid aptamers in microbial infections

Aptamers as smart ligands for nano-carriers targeting

Anti-inflammatory activity of bioactive compounds from microalgae and cyanobacteria by focusing on the mechanisms of action

Simultaneous detection of bovine and porcine DNA in pharmaceutical gelatin capsules by duplex PCR assay for Halal authentication

Silymarin antiproliferative and apoptotic effects: insights into its clinical impact in various types of cancer

Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers

Anti-cancer drug delivery using carbohydrate-based polymers

Trends in the design and development of specific aptamers against peptides and proteins

Peptide dendrimers as valuable biomaterials in medical sciences

Marzieh Rashedinia | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Marzieh Rashedinia | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assoc Prof Dr Marzieh Rashedinia, Shiraz university of medical sciences, Iran

Based on the provided information, Assoc. Prof. Dr. Marzieh Rashedinia appears to be a strong candidate for the Best Researcher Award. Here’s a summary of her qualifications and contributions:

Publication profile

google scholar

Education

  • Ph.D. in Toxicology (2013), School of Pharmacy, Mashhad University of Medical Sciences, Iran.
  • M.Sc. in Toxicology (2009), School of Pharmacy, Shiraz University of Medical Sciences, Iran.
  • B.Sc. in Cell and Molecular Biology (2005), School of Sciences, Shiraz University, Iran.

Research Focus

  • Ph.D. Thesis: Evaluation of neuroprotective effects of Crocin on Acrolein-induced neurotoxicity in rats.
  • M.Sc. Thesis: The effect of ATP supplier compounds on Zinc phosphide toxicity in HepG2 Cells.

Research Techniques and Experiences

  • Cell culture, Toxicology screening tests, Animal behavior testing, Western blotting, Proteomics, Real-Time PCR, Immunoprecipitation, HPLC, In vivo and in vitro toxicity testing, Food contaminant analysis, Cell and molecular mechanisms of toxicity.

Notable Publications

  • “Silymarin: A promising pharmacological agent for treatment of diseases” – Iranian Journal of Basic Medical Sciences, 2011.
  • “Evaluation of diazinon-induced hepatotoxicity and protective effects of crocin” – Toxicology and Industrial Health, 2015.
  • “Effects of sodium benzoate on learning, memory, and oxidative stress in mice” – Journal of Biochemical and Molecular Toxicology, 2018.
  • “Identification of possible cytotoxicity mechanism of polyethylenimine by proteomics analysis” – Human & Experimental Toxicology, 2016.

Abstracts and Congress Presentations

  • Syringic acid effects on oxidative stress in diabetic rats – 3rd World Congress and Expo on Traditional and Alternative Medicine, Berlin, 2019.
  • Syringic acid for renal oxidative stress management – 9th World Congress on Targeting Mitochondria, Berlin, 2018.
  • Glycyrrhizic acid modulates aluminium-induced oxidative stress – 6th National Congress on Medical Plants, Tehran, 2017.

Summary

Assoc. Prof. Dr. Marzieh Rashedinia has made significant contributions to the field of toxicology through her research on neuroprotection, oxidative stress, and food contaminants. Her extensive experience with advanced research techniques and impactful publications underlines her suitability for the Best Researcher Award.

Publication top notes

β€œSilymarin”, a promising pharmacological agent for treatment of diseases

Evaluation of diazinon-induced hepatotoxicity and protective effects of crocin

Effects of sodium benzoate, a commonly used food preservative, on learning, memory, and oxidative stress in brain of mice

Identification of possible cytotoxicity mechanism of polyethylenimine by proteomics analysis

Antioxidant activity of Pistacia vera fruits, leaves and gum extracts

Design and development of vitamin C-encapsulated proliposome with improvedΒ in-vitroΒ andΒ ex-vivoΒ antioxidant efficacy

Vortex-assisted dispersive liquid-liquid microextraction based on hydrophobic deep eutectic solvent for the simultaneous identification of eight synthetic dyes in jellies and …

Neuroprotective effect of syringic acid by modulation of oxidative stress and mitochondrial mass in diabetic rats

Ellagic acid improves muscle dysfunction in cuprizone-induced demyelinated mice via mitochondrial Sirt3 regulation

Effect of sodium benzoate on liver and kidney lipid peroxidation and antioxidant enzymes in mice

Sihe Zhang | Pharmacology | Best Researcher Award

ProfΒ SiheΒ Zhang |Β Pharmacology |Β Best Researcher Award

Professor atΒ Β Nankai University,Β China

Si-he Zhang is a distinguished cell biologist and professor at Nankai University, China. He earned his PhD in Cell Biology from the Fourth Military Medical University and has held various academic positions including Associate Professor at Lund University Hospital, Sweden. His research focuses on cancer biology, particularly in developing targeted therapies using antibodies and nanoparticle-based drug delivery systems. Zhang has authored numerous influential publications and holds several key patents in the field. He has received prestigious awards, including the Chinese Outstanding Patented Invention Gold Award and the National Prize for Progress in Science & Technology. Zhang also serves on several scholarly committees and as a consultant for leading biopharmaceutical companies in China.

Profile

Scopus

Education:

  • PhD in Cell Biology, Fourth Military Medical University, China, 2001-2004
  • M.A. in Genetics, Jinlin University, China, 1996-1998
  • B.S. in Genetics, Northwest A&F University, China, 1991-1995

Positions Held:

  • Tenured Full Professor, Nankai University, China (2020-present)
  • Tenured Associate Professor, Nankai University, China (2012-2019)
  • Postdoctoral Scientist, Lund University Hospital, Sweden (2006-2009)
  • Associate Professor, Fourth Military Medical University, China (2005-2011)
  • Lecturer, Fourth Military Medical University, China (2000-2005)
  • Teaching Assistant, Fourth Military Medical University, China (1998-2000)

Major Awards:

  • Gold Award for Chinese Outstanding Patented Invention, WIPO-SIPO (2010)
  • National Prize for Progress in Science & Technology, China (2005)

Citations:

  • Citations: 948
  • Documents Contributed: 43
  • h-index: 15

Publications Top Notes

  • Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity
    • Qi, F.-Z., Su, H.-S., Wang, B., …, Chen, Z.-N., Zhang, S.-H.
    • MedComm, 2024, 5(3), e512
  • Suicide gene delivery by morphology-adaptable enantiomeric peptide assemblies for combined ovarian cancer therapy
    • Song, N., Sun, Z., Wang, B., …, Zhang, S., Yu, Z.
    • Acta Biomaterialia, 2024, 175, pp. 250–261
  • Vesicle-mediated transport-related genes predict the prognosis and immune microenvironment in hepatocellular carcinoma
    • Ye, Z., Wang, Y., Yuan, R., …, Qian, L., Zhang, S.
    • Journal of Cancer, 2024, 15(12), pp. 3645–3662
  • Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma
    • Wang, B., Qi, F.-Z., Chen, P., …, Chen, Z.-S., Zhang, S.-H.
    • International Journal of Biological Sciences, 2024, 20(5), pp. 1634–1651
  • Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress
    • Sun, Z., Huang, J., Fishelson, Z., Wang, C., Zhang, S.
    • Biomedicines, 2023, 11(7), 1971
  • GRP75-driven, cell-cycle-dependent macropinocytosis of Tat/pDNA-Ca2+ nanoparticles underlies distinct gene therapy effect in ovarian cancer
    • Su, L., Sun, Z., Qi, F., …, Chen, Z., Zhang, S.
    • Journal of Nanobiotechnology, 2022, 20(1), 340
  • Novel GIRlncRNA Signature for Predicting the Clinical Outcome and Therapeutic Response in NSCLC
    • Zhang, Q., Liu, X., Chen, Z., Zhang, S.
    • Frontiers in Pharmacology, 2022, 13, 937531

 

Xintian Shao | Pharmaceutical Science Award | Best Researcher Award

Dr. Xintian Shao | Pharmaceutical Science Award | Best Researcher Award

Dr. Xintian Shao, Shandong First Medical University & Shandong Academy of Medical Sciences, China

Dr. Xintian Shao earned her PhD in Microbiology and Biochemical Pharmacy from Shandong University, China, under the guidance of Prof. Peixue Ling. She expanded her expertise as a Visiting Scholar in Cancer Biology at the University of Cincinnati, USA, mentored by Prof. Jiajie Diao. Currently serving as an Associate Professor at Shandong First Medical University, her research has yielded 10 impactful publications and secured numerous grants. With two patents to her name, she’s been honored with prestigious awards including the Shandong Medical Science and Technology Award and the Science and Technology Award of Shandong Pharmaceutical Association.

 

Publication ProfileΒ 

Scopus

Education and Academic Achievements πŸ“šπŸ…

Dr. Xintian Shao completed her PhD in Microbiology and Biochemical Pharmacy at the School of Pharmacy, Shandong University, China, under the guidance of Prof. Peixue Ling. She further enriched her expertise as a visiting scholar in Cancer Biology at the University of Cincinnati, USA, mentored by Prof. Jiajie Diao. Her prolific research has resulted in 10 publications, including notable contributions to journals such as Advanced Drug Delivery Reviews and Advanced Science. With multiple patents and prestigious grants to her credit, she has earned recognition including the Shandong Medical Science and Technology Award (2021) and the Science and Technology Award of Shandong Pharmaceutical Association (2022).

Work Experience πŸ’Ό

Dr. Xintian Shao has served as an Associate Professor at the School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, China. Her role involves not only teaching and mentorship but also continued research contributions in her field.

Research Focus

Dr. Xintian Shao’s research primarily focuses on subcellular imaging and targeted drug delivery systems. Her work delves into the intricate dynamics of organelle interactions, particularly within mitochondria and lysosomes, employing cutting-edge super-resolution imaging techniques. She explores novel methods for visualizing drug molecules within living organisms, enhancing our understanding of drug distribution and efficacy. With a keen interest in membrane biology and organelle-specific targeting, her contributions shed light on fundamental cellular processes and hold promise for advancements in drug delivery and therapeutics.

Publication Top NotesΒ 

  1. “Single-organelle localization-based super-resolution imaging for subcellular molecules micro-dynamics” by Fang, G. et al., Coordination Chemistry Reviews, 2024.
  2. “Enhanced optical imaging and fluorescent labeling for visualizing drug molecules within living organisms” by Sun, T. et al., Acta Pharmaceutica Sinica B, 2024.
  3. “Mitochondrial nucleoid condensates drive peripheral fission through high membrane curvature” by Chen, Q. et al., Cell Reports, 2023.
    Cited by: 1
  4. “Graphene Oxide Nanosheets Induce Mitochondrial Fragmentation by Cutting through Membrane” by Shao, X. et al., ACS Materials Letters, 2023.
    Cited by: 4
  5. “Subcellular visualization: Organelle-specific targeted drug delivery and discovery” by Shao, X. et al., Advanced Drug Delivery Reviews, 2023.
    Cited by: 7
  6. “Recent advances in fluorescent probes of peroxynitrite: Structural, strategies and biological applications” by Sun, J. et al., Theranostics, 2023.
    Cited by: 8
  7. “Single Image Capture of Bioactive Ion Crosstalk within Inter-Organelle Membrane Contacts at Nanometer Resolution” by Fang, G. et al., Small Methods, 2022.
    Cited by: 8
  8. “Lysosome-Targeted Biosensor for the Super-Resolution Imaging of Lysosome–Mitochondrion Interaction” by Wang, H. et al., Frontiers in Pharmacology, 2022.
    Cited by: 4
  9. “Super-resolution image-based tracking of drug distribution in mitochondria of a label-free naturally derived drug molecules” by Wei, Y. et al., Chemical Engineering Journal, 2022.
    Cited by: 19
  10. “Prefused lysosomes cluster on autophagosomes regulated by VAMP8” by Chen, Q. et al., Cell Death and Disease, 2021.
    Cited by: 24

 

 

Kavitha Jayaseelan | Pharmaceutical Science | Best Faculty Award

Dr. Kavitha Jayaseelan | Pharmaceutical Science | Best Faculty Award

Dr. Kavitha Jayaseelan, SRM COLLEGE OF PHARMACY, India

πŸŽ“ Kavitha Jayaseelan is an accomplished educator with 12+ years of experience, currently serving as Associate Professor at SRM College of Pharmacy. With expertise in Bio-analytical Method Development and Validation, she holds a Ph.D. from SRM Institute of Science and Technology. Kavitha is dedicated to enhancing student learning and has received accolades such as the Best Teacher Award by SIMATS. Her proactive involvement in university agendas, coupled with her role as a reviewer for esteemed journals, underscores her commitment to academic excellence. Passionate about research, she continually seeks to empower young minds and contribute to the field of pharmaceutical analysis. πŸ“š

Publication Profile:

Scopus

Orcid

Education:

πŸŽ“ Kavitha Jayaseelan embarked on her academic journey with a Bachelor of Pharmacy from SRM College of Pharmacy, securing a merit seat and graduating with distinction in 2006. She furthered her studies with a Master of Pharmacy in Pharmaceutical Analysis from JSS College of Pharmacy, again earning a merit seat and achieving distinction in 2009. Driven by her passion for research, Kavitha pursued a Ph.D. in Pharmacy at SRM College of Pharmacy, SRM Institute of Science and Technology, completing her doctoral studies from 2012 to 2018. Her academic excellence and dedication to the field of pharmacy shine through her educational accomplishments. πŸ“š

Awards:

πŸ… Kavitha Jayaseelan’s career is adorned with notable achievements and accolades. She was honored with the Best Interactive Speaker Award at the 2nd Global Virtual Summit on Pharmaceutical & Novel Drug Delivery Systems in Rome, Italy, in March 2023. Recognized for her exceptional teaching prowess, Kavitha clinched the Best Teacher Award by SIMATS – Global Iconic Excellence Award in August 2022. As a respected academic, she serves as a reviewer for esteemed journals like Critical Reviews in Analytical Chemistry. Her academic brilliance is underscored by gold medals in her Master of Pharmacy program and recognition from the IPA Nilgiris branch. πŸŽ–οΈ

Industrial Experience:

πŸ’Ό Kavitha Jayaseelan gained valuable industrial experience as a Trainee Chemist at Retort Pharmaceuticals Pvt. Ltd., where she worked in Quality Control from September 2006 to June 2007. This stint provided her with practical insights into pharmaceutical manufacturing processes and quality assurance protocols. Immersed in the pharmaceutical industry, Kavitha honed her skills in ensuring product quality and compliance with regulatory standards. Her time in this role equipped her with hands-on experience that complemented her academic pursuits, enriching her understanding of real-world applications in pharmaceutical analysis. This industrial exposure further strengthened her expertise and commitment to excellence in her field. 🏭

Training Experience:

πŸŽ“ Kavitha Jayaseelan underwent specialized training at CADRAT, JSS College of Pharmacy, focusing on Bio-analytical method development and Bioequivalence studies from April 2008 to February 2009. This immersive training provided her with in-depth knowledge and practical skills in the critical areas of pharmaceutical analysis. Engaging in bio-analytical method development and bioequivalence studies equipped Kavitha with the expertise needed to analyze pharmaceutical compounds and ensure their efficacy and safety. This training experience augmented her academic foundation, empowering her to contribute meaningfully to the advancement of pharmaceutical research and development. Kavitha’s dedication to continuous learning and professional development is evident through her pursuit of specialized training opportunities. πŸ“š

Research Focus:

πŸ”¬ Kavitha Jayaseelan’s research focus lies primarily in analytical and bioanalytical techniques for pharmaceutical quantification. Her extensive contributions to various journals underscore her expertise in spectrophotometric and chromatographic methods for drug analysis, including UV spectrophotometry and HPLC. Kavitha’s research encompasses diverse areas such as method development and validation, multivariate calibration techniques, and applications in pharmaceutical formulations. Her dedication to advancing analytical chemistry is evident through her comprehensive exploration of drug quantification methodologies, aiming to enhance accuracy and efficiency in pharmaceutical analysis. Through her research endeavors, Kavitha endeavors to contribute significantly to the pharmaceutical industry’s quality control and drug development processes. πŸ§ͺ

Publication Top Notes: